Yüklüyor......
Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)
PURPOSE: Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue sarcomas. Combining Hsp90 inhibitors to enhance endoplasmic reticulum stress with mTOR inhibition results in dramatic MPNST shrinkage in a genetically engineered MPNST mouse model. Ganetespib is an injectable poten...
Kaydedildi:
| Yayımlandı: | Sarcoma |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7013290/ https://ncbi.nlm.nih.gov/pubmed/32089640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5784876 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|